Cancer Immunotherapy: A Preclinical Study of Urinary Bladder Cancer
Bacillus Calmette Guerin (BCG), or attenuated Mycobacterium bovis, is the gold standard of immunotherapy in the clinic to treat superficial bladder cancer. However, setbacks remain due to a high recurrence rate, side effects, and BCG-refractory disease. In this thesis, we explored the